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In  the  course  of  investigations  concerned with  problems  relative  to  the 
pathogenesis of primary atypical pneumonia, a  study was undertaken on the 
effects of inoculating mice with both a virus and a bacterium.  The virus em- 
ployed in these experiments is known as pneumonia virus of mice, and will 
hereafter be designated PVM.  The bacterium used is a non-hemolytic strep- 
tococcus, designated streptococcus MG. 
When the first experiments were carried out,  it was  considered that either 
of two possible results might develop; first, that streptococcus MG would have 
no discernible influence en  the course of an  infection induced by PVM;  or 
second, that it might, by contributing to the establishment of a  complex in- 
fection, cause the results to be more severe than those of infections induced by 
PVM alone.  Surprisingly, neither possibility evolved; instead, the inoculation 
of streptococcus MG in mice which previously had been inoculated with PVM 
resulted in a  distinctly less severe infection. 
This unexpected finding was investigated in detail.  It is the purpose of this 
paper to present the results of  studies  on  the  modifying effect  of  certain 
bacterial species upon the course of infection with PVM.  It will be shown that 
a number of bacterial species are capable of causing such an effect and that this 
modification, in striking degree, is obtained when suitable bacteria are given 
either some days before or after inoculation with this virus.  Evidence is pre- 
sented which indicates that this modification phenomenon is the result of inhi- 
bition of multiplication of PVM  in lung tissue  infected with  the virus.  In 
addition, data are presented which suggest that the substance responsible for 
modification with respect to this virus may be polysaccharide in nature. 
Methods 
Virus.NPneumonia virus of mice (PVM), strain 15 (1), was used exclusively.  It was main- 
mined by occasional lung passage in albino Swiss mice and stored  at -70°C.  in a  manner 
identical with that described previously (2). 
Virus Tilration$.NTitrations of PVM  were carried out in groups of albino Swiss mice. 
Serial decimal  dilutions  were employed; each dilution was tested in a group of six mice and in 
each titration at least thirty mice were used.  The technique of titrations, as well as the 
method of calculation  of the 50 per cent maximum  score end point (M.S£0), was identical  with 
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those described previously (2).  Virus  titration  end points are expressed as the logarithm of 
the final dilution of infected mouse lungs. 
Hemagglutination Titrations.--The  technique of hemagglutination  titrations with mouse 
RBC, utilizing serial twofold dilutions, as well as the method of estimating end points, was 
identical with those previously employed (3).  As routine, a  10 per cent suspension in saline 
of the lungs of a group of six mice was prepared, heated in a water bath at 70°C. for 30 min- 
utes, then centrifuged at  8,000  aa,.M,  for I0 minutes, and  the supemate tested  for hemag- 
glutination.  Hemaggiutination  titration  end points are expressed as the logarithm of the 
final  dilution  of such  superuates. 
Reproducibility of Titration End Points.--The results of previous studies (6)  showed that 
virus titration end points with PVM, when carried out under the conditions used in these ex- 
periments, are reproducible to 4-0.15 logarithmic unit.  They also showed that hemaggluti- 
nation titration end points with PVM are reproducible to 4-0.10 logarithmic unit. 
Baaer/a.--The following bacterial species were employed: streptococcus MG (4); Strepto- 
coccus salivarius, type II (4); Pneumococcus, R36A; Group A hemolytic streptococcus, type 6 
(strain $43, glossy); H.. influenzae type B; and/~, coll.  In each instance appropriate broth 
cultures were incubated at 37°C. for 18 hours. 
Polysaccharides.--The  foU0wing  preparations  containing  polysaccharides  of  bacterial 
origin were used: capsular polysaccharide derived from streptococcus lVIG  by means of an alkali 
extraction method described previously (4);  capsular polysaccharide derived from Strepto- 
coccus salivarius, type II, by means of a  water extraction method described previously (4); 
specific somatic antigen t of Shigdla paradysenteriae, type V  (5); a  hapten t derived from the 
latter preparation by a procedure previously described (5); capsular polysaccharide of Pneumo- 
coccus, type I; capsular polysaccharide of Pneumococcus, type III; somatic C polysaccharide 
of Pneumococcus; and capsular polysaccharide  1 of Friedl,'inder bacillus, type B.  In addition, 
the following polysacchafide preparations were employed: blood group A specific substance; t 
agar-agar;  t  gum  acacia;  I Lintner's soluble starch;  x  and heparin.  Unless otherwise stated, 
polysaccharide preparations were tested  at  a concentration of 2 rag.  per  cc. in saline  and had 
been heated at 56°C. for 30 minutes. 
EXPERIMENTAL 
I.  Effect of Bacterial Inoculation on the Results of Infection with PVM 
Effect of Streptococcus MG.--The  effect of intranasal  inoculation  of strepto- 
coccus  MG  on  virus  titration  end  points  obtained  with  PVM  in  mice  was 
tested. 
Groups of mice were inoculated intranasally with dilutions of PVM from 10  -t to 10-' in 
broth containing 10 per cent normal horse serum.  Two days and 4 days, respectively, after the 
virus dilutions had been given, the animals received a second intranasal inoculation i.e. 0.05 
cc., which consisted either of sterile broth or of an 18 hour broth culture of streptococcus MG. 
Both the encapsulated bacterium  (S), as well as a non-encapsulated variant (R), was used. 
Mice which died were autopsied and their lungs examined for the presence and amount of 
pulmonary  consolidation.  Those which  survived the observation period of  12  days  were 
killed and the extent of pulmonary consolidation present in their lungs was recorded.  From 
these data the 50 per cent maximum score end point (7) was determined.  It is of importance 
to point out that the 50 per cent maximum score end point takes into account not only the 
t These  preparations  were  kindly  provided by Dr.  Weather  F.  Goebel,  the  Rockefeller 
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frequency of fatal infections but also the frequency and the degree of pulmonary consolidation 
in mice which die, as well as in those which survive until kiUed  As is true of titrations of 
influenza virus in mice (8), this end point is more reproducible with PVM than any other 
end point so far tested (2).  For convenience, this titration end point will be referred to here- 
after as M.S.50 end point. 
TABLE I 
Results of Titrations of PVM in Mic~ Given Stre)tococcua MG Intranasally 
First inoculation 
0.05 c¢. I.N. 
PVM dilution 
10-1 
10-1 
10s 
10--4 
10-5 
10-1 
10--2 
10-s 
10--4 
10-~ 
In-  Second  inoculation 
ter-  val  0.05 cc. 1.N. 
days 
2  Sterile broth 
2  Strep. MG (S) 
broth culture 
C~  ~g  cC 
~l  CC  C~ 
Sterile broth  None 
Strep. MG (S) 
broth culture 
Virus 
Time of death and extent of pulmonary  Lung  titration  lesion  end point  consolidation in individual mice  score*  bi.S. 50 
Los 
D7~,D7,D7,D8,D8,DIO,S++§  32/35 
D7,D7,D7,D7,D7,D8,S+ +  32/35 
D7,DT,D8,DS,D8,D8,D11  35/35  10  "~.u 
S++,S++,S+,S+,S+  6/25 
S++,S++,S+,S+,S+,S+,S0  7/35 
D7,D8,DS,D9,S+++,S+ ++,  29/35 
S+++ 
D8,D8,Dg,S++,S++,S+ +,  22/35 
S+ 
D9,S+++,S++,S++,S++,  17/35  10  ~0 
S++,S+ 
Dll,S++,S++,S+,S0,S0  9/30 
S+,S0,S0,S0,S0,S0,S0  0/30 
S0,S0,S0,S0,S0,S0,S0  0/35 
S0,S0,S0,S0,S0,S0,S0  0/35 
I.N.  =  intranasal. 
* Numerator ffi sum of arithmetic values 1, 2, 3, 4, and 5 assigned to lung lesions corre- 
sponding to +, ++,  +++,  ++++,  and D++++,  respectively. 
Denominator =  number of mice multiplied by 5 (i.e., maximum possible score). 
D7 ffi mouse died with ++++  pulmonary consolidation on 7th day. 
§ S++  =  mouse survived 12 days but at autopsy showed ++  pulmonary consolidation. 
The results which were  obtained in one part of the experiment are presented 
in detail in Table I.  It will be observed that there is a striking difference in the 
frequency  with  which  fatal infection  and  extensive pulmonary consolidation 
occurred in mice which received streptococcus MG 2 days after inoculation with 
PVM  as  compared  with  those  which  received  broth.  An  amount  of  virus 
(i.e., a dilution of 10-8), which caused complete consolidation of the lungs, and 
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mately 50  per  cent  pulmonary consolidation  and  the  death  of but  a  single 
mouse among those  given  a  broth culture  of streptococcus MG.  Similarly, 
among mice inoculated with a 10  -5 dilution of PVM, those which subsequently 
received broth showed, on the average, approximately 25 per cent pulmonary 
consolidation, whereas those which received streptococcus MG showed,  with 
one questionable exception, no evidence of pneumonia.  The virus titration end 
point (M.S.50) obtained in mice which were given sterile broth was 10  -S .ss; in 
mice which received broth culture of streptococcus MG it was 10-  ~ .bL  The 
difference between these two virus titration end points (i.e., -- 3.85 -- ( -  2.59) = 
TABLE  H 
Effect of Intranasal Instillation of Streptococcus MG on the Results of P V M  Titrations 
in Mice 
First inoculation 
0.05 cc. I.N. 
PVM dilutions 
¢#  $[ 
((  [¢ 
Interval 
days 
Second inoculation 
0.05 co, I.N. 
None 
Sterile  broth 
Strep.  MG  (S) 
....  (R) 
Sterile broth 
Strep. MG (S) 
....  (R) 
Virus 
titration 
end point 
M.S. 50 
Log 
-4.45 
-3.85 
-2.59 
-2.79 
--5.00 
--3.82 
--3.39 
Difference 
from broth 
control 
Log 
--1.26 
--1.06 
w 
--1.18 
--1.61 
Geometric mean ...................................................  -- 1.27 
S  =  encapsulated type-specific bacterium. 
R  =  non-encapsulated variant. 
--1.26 logarithmic units)  indicates that at least 18 times (i.e.,  log 18  --  1.26) 
more virus was required  to cause pneumonia and death in mice given strep- 
tococcus MG as compared with control animals given sterile broth. 
The results which were obtained in the complete experiment are presented in 
Table II.  In this table, as in those which follow, the detailed experimental 
results are condensed as much as possible in the interest of both conciseness 
aud precision, and a  single value, the M.S.50 virus titration end point, is used 
to give quantitative expression to all of the results which were obtained in in- 
dividual mice in each virus titration.  As was indicated above, at least thirty 
mice were used in each titration.  From the data shown in Table II it can be 
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end point was significantly lower in each instance than it was in mice which 
received sterile  broth.  The geometric mean difference  (i.e.  the sum of the 
differences expressed as logarithms  divided by the number of differences)  of 
the titration end points from the corresponding controlend points was -- 1.27 log- 
arithmic units which represents an end point lower by 20.fold.  This surprising 
result indicates that the effect of streptococcus MG was to lessen the conse- 
quences of infection with  PVM.  Because  of the  regularity with which  the 
virus titration end point was lowered, even though the bacterium was given 
as long as 2 or 4: days after the virus had been inoculated, the modifying effect 
was investigated in more detail. 
Streptococcus MG in Mouse Lungs.--Although, as was shown previously (4), 
streptococcus MG is not pathogenic for mice, it was not known for what period 
the bacteria would survive in the lungs of mice following intranasal inoculation. 
Groups of mice  either untreated, or those which had received 1,000  M.S.50 doses of PVM 
24 hours previously, were given undiluted culture of streptococcus MG intranasally~  Ani- 
mals were killed at 2 hour intervals thereafter and cultures were made from the cut surfaces 
of their lungs. 
It was found that the streptococcus  could be recovered from the lungs  of almost all inocu- 
lated mice during the first 10 hours after instillation of the bacteria but that in no instance 
could it be recovered later than the 14th hour and did not later reappear.  It app~rs, there- 
fore, that this microorganism  is incapable of surviving  for more than a relatively short time in 
the mouse  lung and that the period of survival is not increased if the mouse has been infected 
previously by PVM.  The intranasal inoculation of mice with streptococcus  MG did not lead 
to the development of pulmonary lesions discernible either in the gross or on microscopic 
examination. 
Reproducibility  of Modification.--Further  experiments  were  carried  out  to 
determine the reproducibility of the modifying effect of streptococcus MG on 
infection induced with PVM. 
Groups of mice, which had been given appropriate dilutions of PVM intranasally, were 
inoculated with one of the following: sterile broth,  streptococcus  MG culture,  the super- 
natant fluid from such a culture following centrifugation at 10,000 Ra,.g., or sedimented bac- 
terial cells resuspended to original volume in saline. 
The results of this experiment are shown in Table III.  It will be seen that 
in mice, which received either whole culture or resuspended bacterial  cells  3 
days after inoculationwith PVM, thevirus titration end point was significantly 
lower  than  in  mice  which  received  broth  or  culture  supernate.  Moreover, 
when the order of the  inoculations was reversed,  and virus was given 2 days 
after intranasal inoculation of bacteria, similar results were obtained.  It will 
be  evident  also  that  mixing resuspended  bacterial  cells  with  either  normal 
serum or antistreptococcus MG serum had no effect upon modifying activity. 
This immune serum had a titer of 1:5,000 in agglutination tests against strepto- 
coccus MG.  Both the normal and the immune serum were shown to possess 628  vIRus  ol,  MICE (Pw) 
no  neutralizing  antibodies  against  PVM.  The  geometric  mean  difference 
in virus titration end points between the broth controls and the various groups 
of mice which received preparations containing streptococcus MG was --1.79 
logarithmic units; a 60-fold lower end point.  To state this in another way, the 
results obtained indicate that it required 60 times more virus to produce com- 
parable pulmonary disease in mice given streptococcus MG as compared with 
control animals. 
TABLE HI 
E~ec~  of  Streptococcus  MG on  the  Results  of  PVM  Ti#a~ms in  Mice 
First inoculation 
0.05 cc. LN. 
PVM dilutions 
|,  C( 
Sterile broth 
Strep. MG (S) 
"  supemate 
"  ceils 
"  "  -~- Norm. serum 
"  "  +  Anti-MG" 
Interval 
days 
3 
~C 
~t 
C~ 
C~ 
~C 
V|rus  Difference 
Second inoculation  titration  [ram broth 
end point  control  0.05 cx. I.N.  M.S. 50 
Log  Log 
None  --4.43 
Sterile broth  --  4.59  -- 
Strep. MG (S)  -2.35  --2.24 
"  supemate  -4.27  -0.32 
"  cells  -2.46  --2.13 
PVM dilutions  -  3.14 
"  "  --1.19  --1.95 
.....  3.67  +0.53 
"  "  --1.78  --1.36 
"  "  --1.77  --1.37 
"  "  --1.41  --1.73 
Geometric mean (culture supernat~)  +0.10 
"  "  (preparations cont_~inJng sLrep. MG)  --1.79 
Effect of Time Interva/.--Experiments were carried out to determine at what 
time intervals before, as well as after,  inoculation  of the  virus a  significant 
modifying effect could be obtained with cultures of streptococcus MG.  The 
results of these experiments are presented graphically in  Fig.  1 in which the 
logarithm of the virus titer is plotted against the time at which the test materials 
were given in relation to inoculation with the virus.  It is evident that the in- 
tranasal inoculation of mice with sterile broth alone prior to infection by PVM 
is not wholly without effect upon the results of virus infection, as manifest in the 
titration end point.  This was most evident when broth was given either 1 or 
2 days before the virus.  Much more striking, however, is the effect upon the 
virus  titration  end  point  of  the  intranasal  inoculation of streptococcus MG 
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was given, each of the differences in titratiou end point between broth control 
groups and streptococcus MG groups is significant.  The difference was most 
striking on the 2nd or 3rd day before the virus was given but was of almost 
equal extent from the 1st through the 4th day after the virus was inoculated. 
In the total of eighteen experiments with streptococcus MG carried out at 
various  intervals  before or  after  inoculation  with  the  virus,  the  geometric 
mean difference between the observed virus titration end points has a value of 
-  1.62 logarithmic units which corresponds to a 42-fold lower end point, on the 
I 
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FIo.  I. Effect of intranssal  instillation of streptococcus MG, relative to  time, on virus 
tltrstion end points with PVM in mice.  Each end point was determined by the results ob- 
talned in at  least  thirty mice. 
average, in mice given the bacterial culture as compared with those which re- 
ceived sterile broth. 
Effect of Intraperitoneal Injection.--In  all of the  experiments described so 
far, only intranasal inoculation of streptococcus MG was employed.  It seemed 
of importance to determine whether a  similar effect could be obtained if the 
bacteria were given by another route.  In Table IV are shown the results of 
tests analogous  td those already described but with  the difference that  the 
bacterial  culture was  given intraperitoneally.  It  is  obvious  that  in  no  in- 
stance was there a  significant reduction in the virus titration end point even 
though widely different time intervals were employed and large amounts of 
bacteria were injected. 
Various other tests have been done also and, so far, it has not been possible 630  PNEUMONIA  VIRUS OF MICE (PVM) 
to obtain any modifying effect against  PVM unless  active material is given 
intranasally. 
Effect  On Influenza  Virus.--It seemed of considerable interest to determifie 
whether or not a  similar modifying effect could be obtained  with a  differeut 
virus.  For this purpose influenza A virus was selected because it, like PVM, is 
considered to be strictly pneumotropic for mice.  The results of a  number of 
different experiments similar to those already described with PVM are shown 
in Table V.  It is obvious that the intranasal inoculation of streptococcus MG, 
either at various intervals before inoculation with influenza A virus or at inter- 
TABLE IV 
Effect of Intraperiton~ Injection of Streptococcus MG on tl~ Results of 
in Mice 
PVM Ti:rations 
First inoculation 
0.5 cc. LP.* 
Sterile broth .................... 
Strep. MG (0.05 co.)*  ............ 
Sterile broth .................... 
Strep. MG  (0.05 co.) ............. 
Saline  ........................... 
Strep. MG  (0.05 cc.) .............. 
"  (5.0 cc.) .............. 
Interval 
days 
14 
7 
C¢ 
2 
tt 
tt 
Second inoculation 
0.05 cc.I.N. 
PVM dilutions 
at  gC 
Virus 
titration 
md point 
M.S. 50 
Log 
--4.25 
--3.98 
--4.39 
--4.38  i 
-3.24 
-- 4.13 
--3.65 
Difference 
from.  control 
Log 
--0.27 
--0.01 
+0.78 
+0.22 
Geometric mean  ......................................  .................  +0.18 
* I.P.  =  intraperitoneal. 
~: Bacterial cells from indicated quantity of broth ctlltu_~. 
vals after such inoculation, had in no instance a significant effect upon the virus 
titration  end  point.  Exert when  10  times  concentrated  bacterial  cells were 
given 2 days before infection with this virus, there was no discernible reduction 
in titration  end point. 
E.~ect of Various Bacterial Species.--The effect of bacterial species other than 
streptococcus  MG was tested.  In  these  experiments various Gram-positive 
cocci, both encapsulated and  non-encapsulated,  as well as certain Gram-neg- 
ative  bacilli, were  included.  In  each  instance  fresh, live cultures were em- 
ployed.  The results of a number of such experiments are presented in summary 
form in Table VI.  It will be noted  that  in some instances bacterial prepa- 
rations were given 3 days after inoculation with PVM; in other instances the 
bacterial preparations were given first, and 2 days later dilutions of PVM were 
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It will be apparent from the results obtained that each of the Gram-positive 
cocci tested exerted a  very striking modifying effect.  Similarly, both of the 
Gram-negative bacilli tested caused a  marked reduction in the virus titration 
end point as compared to appropriate controls.  It shouM also be pointed out 
that the cell-free supernate obtained from a  culture of Streptococcus  salivarius, 
type II, was without effect as, it will be recalled, were similar supernates de- 
rived from streptococcus MG cultures.  The geometric mean difference from 
TABLE V 
Effect  of Intranasal In~t~lal~n of Streptococcus MG  on  I~  Results of Influenza A  Virus 
Tilralions in Mice 
First inoculation 
0.05 cc. IHq. 
Sterile broth .................... 
Strep. MG  ...................... 
Sterile broth .................... 
strep. MG ..... 
Strep.  MG  ...................... 
"  "  (I0 X concentration)  ... 
IAV dilutions .................... 
St  (( 
•  I  J  0  ................ 
d~;  (( 
Interval 
days  I 
titration  ]Difference 
Second inoculation  end point  from  control 
0.05 cc. I.N.  M.S.  50  Log 
IAV* dilutions 
"  "  --0.10 
"  "  --0.33 
"  "  -0.45 
"  "  --0.33 
Sterile broth 
Strep. MG  --0.41 
Sterile broth 
Strep. MG  4-0:23 
Geometric mean ........................................................  [  -0.23 
* IAV  -  influenza A virus (PR8 strain), 
the controls of the virus titration end points, obtained when these bacterial 
preparations had  been  inoculated,  was  --2.07  logarithmic  units,  which  cor- 
responds to an end point lower by approximately 120-fold. 
Effect of Bacterial Concentrallon.--A  series of tests was carried out to deter- 
mine what effect the concentration of the bacterial suspension would have on 
modification with PVM.  Four species of Gram-positive cocci and one species 
of Gram-negative bacilli were tested in a  concentration equivalent to that of 
the undiluted culture and also in a concentration 10 times that of the culture. 
In each of these  experiments the  bacterial preparations were inoculated  in- 
tranasally 2 days before the virus dilutions. 632  PZ~Lr~O~IA  wRus  o~ race  (PvM) 
In Fig. 2 are presented  graphically the results which were obtained.  The 
difference in virus titration end point obtained in  control mice as compared 
with treated mice is plotted against the concentration of the bacterial suspen- 
sions used.  It will  be observed  that  in  each instance,  as the bacterial con- 
centration was increased, the modifying effect also increased.  The geometric 
mean  difference  in  titration  end  point  with  the  one time  concentrated sus- 
pensions was -1.46 logarithmic units; with the 10 times concentrated suspen- 
sions  this  difference  was  greater  than  -2.20  logarithmic  units.  This rep- 
TABLE VI 
Effect of Intranasal Instillation of Variou.~ Bacterial Species on the Results of P V ~( 
Titrations in Mice 
First inoculation 
0.05 cc. I.N. 
PVM  di1 ,, o.sl  ii  i  i  i  i  i  i  i  i  i 
Sterile broth ............... 
Pneumococcus  R36A  ....... 
Group A hemo]ytlc  strep- 
tococci, type 6 ........... 
Sa~lne .................... 
H. influenza, type B ....... 
g. coil  .................... 
Zn~  it-  Second inoculation 
0.05 co. I.N. 
Sterile broth 
Streptococcus s~irarlus type II 
"  "  supernate 
"  "  cells 
PVM dilutions 
l~  {ll 
Virus 
:itratlon 
nd point 
M.S. 50 
Log 
--4.59 
--2.48 
--4.36 
--2.75 
--3.14] 
-0.81 
-0.83 
-3.00 
-  1.35 
--0.79 
Differ- 
ence from 
control 
Los 
m 
--2.11 
--0.23 
--1.84 
--2.33 
--2.31 
m 
--1.65 
--2.21 
Geometric mean (preparations containing bacteria) ...........................  -2,07 
resents,  on  the  average,  more  than a  sixfold increase in the modifying effect 
with a  tenfold increase in bacterial concentration. 
Effect of Heat-KiUeA Baztcria.--Inasmuch as the experiments so far described 
were carried out with live bacteria, it was of interest to determine whether heat- 
killed bacteria would be capable of exerting a similar modifying effect.  A con- 
siderable series of experiments to test this point was carried out and the results 
of some of the more pertinent are summarized in Table VII.  Heat-killed sus- 
pensions of streptococcus MG were given intranasally either 2 days before or 
after inoculation with dilutions of PVM.  It will be seen that heating bacteria 
for 30 minutes at 56, 70, or 80°C. caused no significant change in their modifying 
activity with respect  to  the virus.  The geometric mean difference in virus ]~. L. HORS]~ALL~  yR.~  AND  M.  MCCARTY  633 
titration  end points from the  controls was -1.63 logarithmic units; a 42-fold 
lower end point.  The results of these experiments led us to hope that it might 
be possible to separate from the bacterial cells the substance responsible for this 
phenomenon.  One of the chief objectives of this investigation was to learn the 
chemical nature of the substance. 
I, 
-1.(  f  f 
lx  lOx 
Concentz~on o~ bacte~ial culture 
FIo. 2.  Effect  of intranasal  instillation  of different  concentrations  of various  bacterial 
species on virus titration  end points with PVM in mice.  The bacteria were given 2 days 
before the virus.  Each end point was determined by the results obtained in at least thirty 
mice.  Arrows  indicate that the difference  in titer was greater than that shown. 
H.  Effect of Polysacckaride  Preparations on the Multiplication of PVM 
in the Mouse Lung 
Up to this point all experiments had been carried out in vivo and they required 
very large numbers of animals, a  minimum of thirty mice for  each  titration. 
They also required considerable time, a minimum of 12 days.  Consequently, 
an effort was made to obtain results more rapidly and with fewer animals. 
It  will  be recalled  that PVM  possesses  the capacity to cause  agglutination  of mouse ery- 
throcytes (3).  It has been shown that hemagglutination  is caused by the virus  particles 
themselves and  that  the  hemagglutination technique  can  be  used  to  measure the  concentration 634  V~U~OmA  V~US  O~  race  (vvM) 
of virus present in infected lungs (3).  Efforts were directed toward devising a  technique 
whereby the modifying effect could be studied  by means  of  the hemagglutination phenom- 
enon.  Although it had  been shown previously (3)  that in the infected mouse lung the in- 
crease in virus and in hemagglutination titers parallel each other  very closely during the first 
7 days after intranasal  inoculation with PVM, it was not known whether the size of the virus 
inoculum would significantly affect the shape of the curve of virus multiplication, 
Rate of Multiplication  of PVM.--Experiments were carried out to determine 
this and also to determine more accurately on what day after inoculation with 
the virus it could be expected that maximum hemagglutination  titers would be 
TABLE VII 
F.ffea of Intranasal InailIa~ion of Heal-Killed Streptococcus MG on the Results of PVM 
TitraJions in Mice 
In~-vai  Difference  First inoculation  Second lnoculatlon  [tom control 
0.05 co. I.N.  0.05  co. I.N.  Log 
days 
PVMdilutions ................. 
4~  ~4 
Sterile broth ................... 
Strcp. MG .................... 
....  (70oc.)* ............. 
~l~ne  ..................  ,  ...... 
Strep. MG (10 X concentrated).. 
G4  4;  ~4 
(70°C.)  *  ..................... 
Strep.  MG  (I0 X  concentrated) 
(80°C.)  * ..................... 
None 
Strep.  MG  -- 1.95 
....  (SS°C.)  *  -1.09 
PVM dilutions 
,,  ,4  -  1.95 
,,  44  --1.21 
"  "  --2.19 
"  "  --1.42 
"  "  --1.50 
Geometric mean ..............................................  -- 1.53 
* Heated for 30 minutes at indicated temperature. 
present in the lungs of infected animals.  The results of these experiments are 
presented graphically in Fig. 3.  The logarithm of the hemagglutination titer 
is plotted against time after inoculation with PVM.  Three different amouuts 
of virus were used; 10, 100, and 1,000 M.S.50 doses.  It will be noted that there 
is very little difference between the  two curves obtained when either  100 or 
1,000 doses of virus was given and that when no more than 10 doses was inocu- 
lated the curve was not greatly different from the others.  With 100 or 1,000 
doses of virus maximum titers were obtained on the 6th day, and were main- 
tained through the 7th day after inoculation. F.  L.  HORSFALL, JR.)  AND M.  MCCARTY  635 
Extracts of Streptococcus MG.-- 
CeU-free extracts of streptococcus MG were prepared in the following manner: Extract B- 
concentrated bacterial cells were extracted at 37°C. in the presence of purified lysozyme prep- 
aration from egg white at a concentration of 0.5 rag. per cc.  Extract D- packed bacterial 
cells were ground with powdered glass and extracted with saline.  Both extracts were rendered 
essentially cell-free by centrifugation at 10,000 It.P.M.  The modifying effect of the extracts 
was measured in the following  way: Each of a group of six mice was given 0.05 cc. of extract 
intranasally and 2 or 3 days  later each was given 100  M.S.50 doses of  PVM intranasally. 
On the 5th, 6th, 7th, and 8th days, respectively, after inoculation of the virus groups of mice 
were killed and suspensions of their lungs, following appropriate  treatment, were tested  for 
hemagglutination. 
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Fro. 3. Relation between hemagglutination titer of lung suspensions, time after intranasal 
inoculation, and quantity of PVM given mice.  Each end point was determined by the re- 
sults obtained  in a group of at least six mice. 
The results of one such experiment are shown in Table VIII.  It will be seen 
that, when saline was given before the virus, the hemagglutination  titers reached 
maximal levels between the 6th and 8th days after inoculation as was to be 
expected from the control curves shown in Fig. 3.  It will be noted also that 
with mice, which were given a cell-free extract of streptococcus MG either 2 or 
3 days before the virus, hemagglutination was either not demonstrable or the 
titers found were much lower than in comparable controls.  The geometric 
mean difference in the hemagglutination titers for the treated animals as com- 
pared to the controls was -- 1.83 logarithmic units;  a reduction  in  titer of 68-fold. 636  ~tr~OmA  vinos  or  race  (Pw) 
It was of some importance  to determine with what reproducibility the modi- 
fying effect  could be  demonstrated  under  the  conditions  just  described.  In 
Table  IX  are shown the results of three tests carried out with one cell-free ex- 
tract  of  streptococcus  MG  and  six  tests  carried  out  with  another.  In  each 
instance the extracts were given intranasa!ly 2  days before  the mice received 
TABLE  VIII 
E.~ect of Intran~sal Inslilla~ion of Cell-Free  Extracts of Streptococcus MG on Multiplication 
of PVM in Mouse Lungs 
Hemagglu- 
First inoculation  Interval  Second  inoculation  Interval  tlnstion titer* 
0.05 cc. I.N.  0.05 co. I.N.  Log 
days  days 
SaGne  2  PVM  5  -  1.81 
(100 M.S. 50) 
"  "  "  "  6  --2.11 
"  "  "  "  7  --2.41 
"  "  "  "  8  --2.71 
Extract D  2  "  "  5  0.00 
"  "  "  "  "  6  0.00 
"  "  "  "  "  7  --0.60 
"  "  "  "  "  8  --0.90 
Saline  3  "  "  5  --1.81 
"  "  "  "  6  --1.98 
"  "  "  "  7  -2.58 
"  "  "  "  8  --2.71 
Extract D  3 
lc  cc  c~ 
5  0.00 
6  -0.60 
7  --1.38 
8  0.00 
Difference  from 
comparable 
control 
Log 
m 
--1.81 
--2.11 
--1.81 
--1.81 
--1.81 
--1.38 
--1.20 
-2.71 
Geometric mean ....................................................  -- 1.83 
* Titer of mouse lung suspensions. 
100 doses of virus and  the lungs were removed  from each group of animals  6 
days after inoculation with PVM.  It  will be apparent  that  the irregularities 
in the results obtained were not very striking.  The differences observed in the 
hemagglutination  titers with the control and  treated groups, respectively, had 
a  geometric mean  value  of  -- 1.39  logarithmic units with  a  mean  deviation of 
-4-0.28  logarithmic unit,  corresponding  to  a  25-fold  reduction  in  titer with  a 
mean  deviation of q-twofold. 
Stability of Active Component.--On the basis of these  results it appeared  fen- F.  L.  HORSFALL,  JR.,  AND  M.  McCARTY  637 
sible to undertake a  study of the effects of various procedures upon the modi- 
fying activity of cell-free extracts of streptococcus MG.  The results obtained 
with some of the more pertinent procedures are shown in Table X.  In this 
series of experiments, as in those just described, the test materials were given 2 
days before the virus and mouse lungs were removed 6 days after inoculation 
with it. 
It was found that the activity of ce]l-free extracts was not altered by heating 
at 100°C. for 30 minutes; that the active substance in such extracts was not 
TABLE IX 
E~ea of Intranasal Instillation of Stre~lococcus MG Ex#acts on Multiflication  of PVM 
in Mouae. Lungs 
First  inoculation 
0.05 co.  I.N. 
Extract B 
41  ~¢ 
41  44 
Extract D 
4l  14 
14  I1 
11  44 
14  41 
14  14 
Interva]  Second  inoculation  interval 
0.05 co.  I.N. 
days  days 
2  6  PVM 
(IO0 M.S. 5O) 
Ii  14 
41  il 
II  Z¢ 
44  [| 
4~  41 
44  44 
44  L4 
41  11 
6 
Ii 
c¢ 
¢c 
Hemag~lutination 
Uter* 
Control  Treated 
mice  mice 
Log  Log 
--2.88  --1.10 
"  --1.23 
--2.72  --1.08 
"  --1.71 
--2.78  --1.50 
--2.72  --1.20 
"  --1.51 
--2.88  --1.66 
--2.11  0.00 
Geometric  mean ............................................... 
Difference 
from 
control 
Los 
--1.78 
--1.65 
--1.54 
-i.17 
--1.18 
-1.52 
-1.21 
-1.22 
-2.11 
I 
Deviation 
from 
mean 
+0.38 
+0.26 
+0.25 
--0.22 
--0.21 
+0.13 
--0.18 
--0.17 
+0.72 
-4-0.28 
* Titer of mouse lung suspensions. 
dialyzable; that it was precipitable by half-saturated ammonium sulfate, and 
also by 80 per cent ethyl alcohol, and that it was not significantly altered by 
brief treatment with N/10 NaOH or HCI.  Of more interest was the finding 
that  the  activity of the  extracts was  unaffected by incubation  with;  (1)  a 
mixture of crystalline trypsin and chymotrypsin; (2) crystalline ribonuclease; 
and (3) highly purified desoxyribonuclease.  Each enzyme was used in a con- 
centration  of 0.1  mg.  per  cc.  It  is  apparent  that  none  of  the  procedures 
enumerated caused any striking reduction in the activity of the extracts.  The 
geometric mean difference of the hemagglutination titers from the controls was 
--1.75 logarithmic units; a reduction in titer of 50-fold~  These results indicate 
that the substance responsible for the modifying effect is remarkably stable 
and is relatively large with respect to molecular dimensions.  In casting about 538  PNEUMONLA wus  or  race  (Pw) 
among the various classes of substances which might be expected to withstand 
all of the procedures employed, it seemed probable that substances of poly~c- 
charide  nature  should  be  considered.  By means  of precipitation  tests  with 
antistreptococcus MG serum,  it was shown that both extracts  B  and D  con- 
tained approximately 2 rag, per cc. of specific capsular polysaccharide (4). 
Effect of Polysaccharide Preparations.--A  number of different polysaccharide 
preparations and certain related substances were tested as a  consequence.  In 
Table XIare shown in summary lotto'the results of certain of these experiments. 
TABLE X 
E.ffext of Various Proced~r~ on .4aldty of Call-Free Extract~ of Streptococcus MG 
First inoculation 
0.05 cc. I.N. 
ts~c't  Procedure 
[ 
B 
D 
Itl  ] 
"  [ 
f¢ 
None 
100  ° C. 30 mill. 
Dialysis ~$. saline 
Ppt. ~ sat. (NH&SO, 
Ppt. 80 per cent alcohol 
N/10 NaOH 
N/10 HCI 
None 
Trypsin +  chymotrypsin 
Ribonudessc 
Desoxyribonuclease 
Inter-  Second inoculation 
val  0.05 cc. I.N. 
~ys 
2  PV~ 
(100 M.S. 50) 
C~  Lt 
|(  GI 
lat~ 
d~y# 
6 
CC 
Hemagglutination 
titer* 
Coutrol  ~  Treated 
mice  mice 
Log  Log 
--2.88  --1.10 
"  -1.35 
"  -1.10 
"  --0.60 
"  --1.61 
"  --1.89 
"  --1.14 
--2.72  ! --1.20 
Ot  --0,9~ 
"  --0.84 
"  O.OC 
Difference 
from 
control 
Log 
-I.78 
-1.53 
-1.78 
-2.28 
-1.27 
-0.99 
-1.74 
--1...<2 
--1.82 
--1.88 
-2.72 
Geometric mean .........................................................  -  1.75 
* Titer of mouse lung suspensions. 
A standard procedure was followed.  In e~ch instance 0.I rag. of the test substance  was 
given intranasally  to each mouse and 2 days later the mice received, by the same route, I00 
M.S.50  doses of PVM.  The lungs of these animals as weU as those of control mice were 
removed 6 days after inoculation with the virus and the hemagglutination  titers determined. 
Each preparation was tested in two or more separate experiments. 
It was found that  preparations  of the  capsular  polysaccharide of strepto- 
coccus MG,  the  capsular  polysaccharide  of Friedl~nder  bacillus  type  B,  the 
specific somatic antigen of Shigella paradysent~iae  type V, as well as a  hapten 
derived from the same preparation, blood group A specific substance, and ordi- 
nary  agar-agar,  each  exerted  a  very  striking  modifying  effect  under  the 
conditions of these experiments.  The geometric mean difference of the hemag- ~'.  L.  HORSFALL~ ~R.~ AND  M.  McCARTY  639 
glutination titers obtained in  all of the  experiments  carried  out  with  these 
preparations was --1.89 logarithmic units; a reduction in titer of 78-fold. 
TABLE XI 
E.fea of Intranasal I~ of Various Pdysacdu~ Prepara~ons on Multlpl~ 
of PVM in Mouse Lungs 
First inoculation  l  0.05 cc. I.N,  Interval  Second  inoculation 
0.1 rag.  0.05 co. I.N. 
Streptococcus  MG,  capsular  polysae- 
charide ............................ 
Friedlander type B,  capsular polysac- 
chsride  ............................ 
Shlgdla paradysente6a¢, type V, antigen.: 
"  "  "  "  hapten.. 
Blood group A specific substance ....... 
A~ar  ................................ 
PVM 
(100 M.S. 50) 
~C  ~t 
Interval 
days 
6 
II 
II 
41 
It 
Geometric mean ................................................. 
Pneumococcus  type I, capsular polysa'c- 
charide  ............................ 
Pneumococcus  type HI, capsular poly- 
saccharide  ......................... 
Pneumococcus  C  polysaccharide  ....... 
Streptococcus  salivarius,  type II, capsular 
polysacchafide  ...................... 
Gum acada .......................... 
Starch, soluble  ........................ 
Heparin ........ 
2  PVM 
(too M.S. SO) 
C~  t~ 
Geometric  mean 
difference  of 
hemagglutination 
titers* from 
controls 
Log 
--1.43 
--1.97 
--1.74 
--2.13 
--1.80 
--2.26 
--1.89 
--0.60 
--0.17 
-0.25 
--0.01 
--0.06 
--0.66 
-0.30 
Geometric mean ...........................................  ......  -  0.29 
* Titer of mouse lung suspensions. 
Surprisingly, it also was found that the capsular polysaccharides of Pneum0- 
coccus, type I  and type III, as well as of Streptococcus salivarius type II, the 
somatic  C  polysaccharide of  Pneumococcus,  as  well  as  gum  acacia,  soluble 
starch and heparin, were almost without modifying effect and that none of them 
caused a  significant reduction in hemagglutination titer.  The geometric mean 
difference in titer in all of the tests carried out with these latter preparations 
was --0.29 logarithmic unit; a  twofold reduction in titer. 
These results appear to lend support to the idea that  the  substance  respon- 640  r= ONIA  vrRrs  or  mcs  (rw) 
sible for the modification observed with PVM is a large, non-diffusible molecule 
which may be polysaccharide in nature.  Unfortunately, however, those sub- 
stances which were found to possess distinct modifying activity with respect to 
this virus are those, among the preparations tested, about which least is known 
as to molecular structure.  So far, it has not been possible to discover any clue 
regarding a possible molecular configuration possessed in common by the sub- 
stances which are active as modifiers against PVM. 
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Fxo. 4.  Effect of intranasal instillation of different quantities of Friedl&nder  polysaccharide 
on  hemagglutination  titer of suspensions of mouse lungs infected with PVM.  The polysac- 
charide preparation was given 2 days before the virus.  Each end  point was determined by 
the results obtained in a group of at least six mice. 
It was of interest to determine how smaU an amount of highly purified mate- 
Hal wouM be capable of exerting a significant modifying effect with respect to 
this virus.  The results of a series of such experiments with Friedl~.nder bacillus 
type B capsular polysaccharide, a highly purified preparation which had been 
autoclaved, are shown in Fig. 4.  The difference in the hemagglutination titer 
obtained as  compared with  that  found with appropriate  controls is plotted 
against the micrograms of polysaccharide given intranasally to each mouse.  It 
will be seen that there was no striking difference in the modifying effectiveness 
of amounts as small as 6 ttg. per mouse as compared with the effect obtained 
with 100 gg. per mouse.  In general, the lungs of mice which received these ¥.  L.  HORSFALL, JR.,  AND  M.  McCARTY  541 
quantities failed to show any capacity to cause hemagglutination.  It will be 
noted that, when quantities as minute as 1.6 t~g. per mouse were given intra- 
nasally, significant modification was observed. 
Effect of Derivatives of Friedl~nder P olysacckaride.--The polysaccharide prepa- 
ration  which  was  used  for these  experiments  seemed especially suitable  for 
further studies.  This preparation was oxidized with M/50 periodic acid at pH 
5.2.  ~  The reactionwas continued until specific serological activity, as judged by 
the  precipitin  reaction,  had  been  destroyed.  Fractions  obtained  at  various 
time intervals during the reaction were tested for their modifying effect as also 
TABLE XH 
Effed of Intranasal Instillation of Friedl~n&r Capsular Polysacd;aride on Multiplication 
of PVM in Mouse Lungs 
First inoculation IM. 
Material 
Friedl~tnder, type B, capsular poly- 
saccharide  ...................... 
Friedl~lnder, type B, capsular poly- 
saccharide  ...................... 
.~m¢, treated with periodic acid ..... 
Same, aldobionic  acid derivative ..... 
~O1E 
mg. 
0.1 
0.0( 
0.1 
0.0( 
1.0 
0.1 
[nt  ~tl 
-5. 
Second inoculation 
LN. 
PVM 
(ioo  M.S. 5O) 
I  Hemaggluti- 
nation titer,*  Interval difference  from 
control 
Log  I" 
-1.90 
--2.10 
--1.80, 
--0.30 
0.00 
* "riter of mouse lung suspensions. 
was the aldobionic acid  a derived from the original polysaccharide by acid hy- 
drolysis. 
The results of experiments with the untreated polysaccharide, the periodic 
acid-oxidized material, and the aldobionic acid, are shown in Table XII.  It 
will be seen that the aldobionic acid showed no evidence of significant modifying 
activity even when amounts as large as 1 rag. were given to each mouse.  The 
material obtained after oxidation of the polysaccharide with periodic acid, how- 
ever, appeared to be equally as effective as the untreated polysaccharide and in 
each instance as little as 6 t~g. per mouse was sufficient to reduce markedly the 
l Oxidation  with periodic  acid was kindly carried out by Dr. Walther F. Goebel,  the Rocke- 
feller Institute. 
s This material was kindly prepared and provided by Dr. Walther F. Goebel,  the Rockefeller 
Institute. 642  vx us  or  (Fv ) 
hemagglutination  titer as compared to controls.  With this quantity a  64-fold 
reduction in titer was observed in both instances. 
It should be pointed out that, following oxidation of the Friedlander  carbo- 
hydrate with periodic acid, the oxidized polysaccharide may be regarded as a 
polyaldehyde which  has  not suffered gross depolymerization as evidenced by 
the fact  that  the  substance,  like the  specific polysaccharide  from which  it  is 
-~.0 
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FIG. 5. Effect of intranasal instillation of FriedlRnder polysacchsride  on hemaggiutlnation 
titer of suspensions of mouse lungs infected with PVM.  Groups of mice were given polysac- 
charide once only, as indicated by the arrow, at various times following inoculation with virus. 
Lungs were removed and tested at times indicated  by the end points.  Control end points 
were obts~ned simultaneously with lungs of mice which had received either saline or 0.1 mg. of 
aldobionic acid at a corresponding  time after inoculation  with virus.  Each end point was 
determined  by the results obtained in a group of at least six mice. 
derived,  does not  diffuse  through  semipermeable  membranes.  The  oxidized 
carbohydrate,  although no longer capable of giving a  positive precipitin  reac- 
tion  in  the  presence  of specific antiserum,  did,  nevertheless,  still  react  with 
homologous antibody as shown by the results of specific inhibition tests.  Aldo- 
bionic acid is, of course,  a  relatively small molecule and is readily dialyzable. 
If molecular integrity is a criterion of activity, one would not expect this latter 
substance to show a modifying effect. 
Interruption of Multiplication.--All  of the experiments, in which the hemag- 
glutination  technique  was  used  to measure the modifying activity of various F.  L.  HORSFALL~ JR.~  AND  M.  McCARTY  643 
substances of bacterial origin, were carried out under standardized conditions. 
In each, the preparations to be tested were given 2 days before 100 M.S.50 
doses of virus was inoculated and the lungs of inoculated animals were removed 
6 days after the virus was given.  It was of obvious importance to determine 
whether polysaccharide materials would, like intact bacterial cells, be capable 
of causing a modifying effect if given at various times after the virus had been 
inoculated. 
A series of experiments to test this point was carried out and the results are 
presented graphically in Fig. 5.  The logarithm of the hemagglutination titer 
obtained is plotted against time after inoculation of the virus.  When either 
saline or the aldobionic acid was given intranasally at various intervals after 
the virus had been inoculated, there was no significant effect; and the curve of 
increase iu hemagglutination titer, i.e.  in virus concentration, with time was 
closely similar to the control curve shown in Fig. 3.  However, when 0.1 mg. 
per mouse of Friedl~xtder polysaccharide was given at various intervals after 
inoculation with the virus, the hemagglutination titers obtained were signifi- 
cantly lower than in control mice.  It should be noted that the reduction in 
titer from the controls was, on the average, inversely proportional to the length 
of time between the inoculation of the virus and the subsequent injection of the 
.  polysaccharide. 
The curves shown in Fig. 5 suggest that relatively little additional increase 
in virus titer occurred after the intranasal  instillation of the polysaccharide. 
It appears, therefore, that this polysaccharide preparation is, like intact bacte- 
rial ceils, capable of inhibiting or interrupting further multiplication  of virus 
even when it is given at a  time when much virus multiplication has already 
occurred.  In order to show this effect, it was essential to give the polysaccha- 
ride before maximal hemagglutination titers had beeu reached.  If the polysac- 
charide was  given 5  days or more after inoculation with PVM,  little  or no 
modifying activity could be demonstrated.  By this time, of course, the virus 
titer had almost, if not actually, reached maximal levels. 
DISCUSSION 
The evidence obtained in this study indicates that a substance or substances 
present in certain bacterial species are capable of exerting a str;_king modifying 
effect upon the course of infection with PVM in mice.  A similar effect is ob- 
tained also with some materials which are not of bacterial origin.  These active 
materials show this effect following intranasal instillation but failed to show it 
following injection by other routes.  Not only do the active substances modify 
the results of infection with  PVM,  but  also, and  of more importance, they 
appear to cause inhibition or interruption of multiplication of the virus.  This 
is most clearly demonstrable if active material  is given  after infection with 
PVM has been established, when actual multiplication of the virus is occurring. 644  P~r~om.A  vm~s oF  MICE (Fw) 
Each of the soluble substances which was found to be active  contained one 
polysaccharide or another.  The most active substances so far tested are, in 
fact, polysaccharide preparations; certain of these preparations  were  highly 
purified and some had been subjected to rigorous treatment.  Yet, in amounts 
as small as a few micrograms per mouse, such polysaccharide preparations show 
distinct modifying effects with respect to PVM.  Not all polysaccharide prepa- 
rations tested are active as modifiers against this virus; a number of materials, 
both of bacterial and of other origin, were without significant effect.  Present 
evidence suggests that the active component is associated with certain highly 
purified polysaccharides and raises the possibility that it may itself be polysac- 
charide in nature.  As yet it has not been possible to obtain evidence as to the 
chemical structure of the active component. 
It appears that active substances are capable of causing a significant altera- 
tion in the phenomena which result ordinarily when PVM is inoculated intra- 
nasally in susceptible mice.  Under appropriate experimental conditions, it can 
be shown that mice given such substances intranasally not only survive the 
inoculation of quantities of virus which are fatal for control animals, but also 
fail to develop pulmonary consolidation as do controls.  In order to show the 
modifying effect, it is not essential to give active substances prior to inocula- 
tion with the virus; closely similar results are obtained when the material is 
given as late as 4  days after the virus.  Present evidence indicates that the 
normal course of infection with PVM can be modified in favor of the host, by 
means of active soluble material, even at a time when demonstrable evidences 
of infection are already present.  However, once maximal infection has devel- 
oped, i.e.  when either full blown pulmonary consolidation or maximal virus 
titer has been reached, active materials appear no longer to be capable of exert- 
ing an appreciable modifying effect. 
Published reports indicate that, in rare instances, one or another substance 
may exert some influence upon infections induced by certain viruses.  In this 
regard, the following seem pertinent:  Infections induced by some strains of the 
largest of known viruses, i.e. those which form elementary bodies and are mem- 
bers of the psittacosis-lymphogranuloma group, appear to be somewhat altered 
by either sulfonamide drugs or penicillin (10).  Certain acridine compounds 
(11) and an analogue of tryptophane (i.e.,  5-methyl tryptophane) (12) appear 
to inhibit the multiplication of some strains of bacteriophage but do so only at 
concentrations which  also  interfere with  growth of the  bacterial host  cells. 
Evidence has been presented (13) to show that tobacco mosaic virus is inacti- 
vated when mixed with a substance derived from yeast and that this inactivator 
is a polysaccharide.  A number of chemical substances, most notably zinc sul- 
fate, have been shown to induce a state of decreased susceptibility to intranasal 
inoculation of poliomyelitis virus (14).  An acridine compound (i,e., nitroak- 
ridin 3582) has been shown to have an inhibiting effect on influenza B virus in 1~.  L. HORSFALL,  ~R., AND  M.  McCARTY  645 
embryonated eggs (15).  With the exceptions noted, it appears that there is 
but-little evidence which indicates that the course of a virus infection can be 
altered significantly, once it has been initiated, by any substance other than 
specific antibodies against the virus itself. 
It is apparent that it would be of considerable theoretical importance to have 
knowledge of the mechanism by which active substances are capable of exerting 
a  modifying effect upon the course of infection induced by PVM.  It seems 
probable  that knowledge of the chemical structure of the substance or sub- 
stances responsible for modification, with respect to this virus, may be necessary 
before it will be possible to understand the mechanism by which the effect 
occurs.  In the absence of decisive information as to the chemical structure of 
the substance, it has not yet been feasible to carry out conclusive experiments 
which would elucidate the uuderlying mechanism.  Nonetheless,  there were 
opportunities to test certain possible mechanisms. 
It will be  recalled  that PVM  enters  into firm combination with suitable 
erythrocytes as weU as with lung tissue from species susceptible to infection 
with the virus (3).  Neither type of combination undergoes spontaneous dis- 
sociation.  Following combination of virus with erythrocytes, agglutination of 
red blood ceils occurs.  Following combination with lung tissue particles, virus 
can be sedimented along with such particles in centrifugal fields of relatively 
small magnitude (9).  It seemed possible that modification might result from 
chemical blockade of virus "receptors" thought to be present on cells  of the 
respiratory tract. 
Numerous experiments were carried out to test this hypothesis but no evi- 
dence in favor of the  theory was obtained.  Preparations which are  highly 
active as modifiers failed to cause any hemagglutination of erythrocytes sus- 
ceptible to agglutination by the virus.  The treatment of erythrocytes under 
various conditions with active preparations failed to yield any evidence of in- 
hibition  of hemagglutination by  the  virus.  Furthermore,  treatmeut  under 
various experimental conditions of lung tissue, or particles derived therefrom, 
with active preparations failed to reduce their capacity to combine with the 
virus.  In the light of these experiments, it seems improbable that modification 
is to be exp]ained on so simple a basis as blockade of virus "receptors" present 
on cells of the lining membrane of the respiratory tract. 
It seems more probable that active preparations may exert their modifying 
effect by competing with PVM for some intracellular system essential to the 
multiplication of this virus.  To devise direct tests for this hypothesis has not 
been possible because at the present time there is no information regarding the 
nature of such systems.  On the other hand, indirect evidence has been ob- 
tained during these studies which is perhaps suggestive.  Most important is 
the fact that the modifying effect with respect to the virus is clearly demon- 
strable even as late as 4 days after infection with the virus has been established, 646  rs~sosr~  wus  or  mcr  (rvM) 
at a  time when much multiplication  of virus has  occurred.  It seems of con- 
siderable  significance,  in  this  same regard,  that  the  extent  of the modifying 
effect appears  to be almost  inversely proportional  to  the  titer  the virus has 
reached at the time when active material is given.  Moreover, it appears that, 
following the  injection  of active polysaccharide preparations  in  infected ani- 
mals, very little, if any, further multiplication  of PVM occurs. 
SIYMMARY 
Evidence is presented which indicates  that certain polysaccharide prepara- 
tions derived from various bacterial species, as well as similar materials not of 
bacterial  origin,  are capable of lessening  the severity of infection with pneu- 
monia virus of mice (PVM) and inhibiting multiplication of the virus in mouse 
lungs infected with this agent.  It seems probable that modification with re- 
spect to the virus is mediated by a substance which may be polysaccharide in 
nature. 
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